EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Resistance mechanisms of tigecycline in Acinetobacter baumannii

Chunli Sun, Yunsong Yu, Xiaoting Hua

Frontiers in Cellular and Infection Microbiology · 09.05.2023 · 13

DOI: 10.3389/fcimb.2023.1141490 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 09.05.2023. Verfasst von Chunli Sun und 2 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang University-University of Edinburgh (ZJU-UoE) Institute, Zhejiang University, Haining, Zhejiang, China. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Acinetobacter Infections. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acinetobacter baumannii is widely distributed in nature and in hospital settings and is a common pathogen causing various infectious diseases. Currently, the drug resistance rate of A. baumannii has been persistently high, showing a worryingly high resistance rate to various antibiotics commonly used in clinical practice, which greatly limits antibiotic treatment options. Tigecycline and polymyxins show rapid and effective bactericidal activity against CRAB, and they are both widely considered to be the last clinical line of defense against multidrug resistant A. baumannii . This review focuses with interest on the mechanisms of tigecycline resistance in A. baumannii . With the explosive increase in the incidence of tigecycline-resistant A. baumannii , controlling and treating such resistance events has been considered a global challenge. Accordingly, there is a need to systematically investigate the mechanisms of tigecycline resistance in A. baumannii . Currently, the resistance mechanism of A. baumannii to tigecycline is complex and not completely clear. This article reviews the proposed resistance mechanisms of A. baumannii to tigecycline, with a view to providing references for the rational clinical application of tigecycline and the development of new candidate antibiotics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acinetobacter baumanniiAcinetobacter InfectionsHumansTigecyclineMinocyclineDrug Resistance, Multiple, BacterialMicrobial Sensitivity TestsAnti-Bacterial Agents

Stichwörter der Autor:innen

Acinetobacter baumanniiantibioticresistanceresistance mechanismtigecycline

Substanzen

TigecyclineMinocyclineAnti-Bacterial Agents

Autor:innen und Institutionen

  • Zhejiang University-University of Edinburgh (ZJU-UoE) Institute, Zhejiang University, Haining, Zhejiang, China.
  • Department of Infectious Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Key Laboratory of Microbial Technology and Bioinformatics of Zhejiang Province, Hangzhou, China.
  • Regional Medical Center for National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Sun, C., Yu, Y., & Hua, X. (2023). Resistance mechanisms of tigecycline in Acinetobacter baumannii. Frontiers in Cellular and Infection Microbiology, 13. https://doi.org/10.3389/fcimb.2023.1141490

Vancouver

Sun C, Yu Y, Hua X. Resistance mechanisms of tigecycline in Acinetobacter baumannii. Frontiers in Cellular and Infection Microbiology. 2023;13. doi:10.3389/fcimb.2023.1141490

BibTeX
@article{Sun2023,
  author = {Sun, Chunli and Yu, Yunsong and Hua, Xiaoting},
  title = {Resistance mechanisms of tigecycline in Acinetobacter baumannii},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2023},
  volume = {13},
  doi = {10.3389/fcimb.2023.1141490}
}
Kostenlos starten →